The third quarter of 2025 has been a period of steady growth and meaningful progress for the Panacea ecosystem. With service updates tailored to the global healthcare market, strategic partnerships to expand technological integration, and active engagement in national policy discussions, MediBloc continues to build a stronger foundation for innovation in healthcare.
Dr.palette Updates for Korea’s Global Healthcare Market
Dr.palette has introduced a series of updates designed to meet the growing demand of Korea’s foreign patient market. As the only EMR in Korea integrated with Google Business, Dr.palette now enables patients—especially international visitors—to book appointments directly through Google Search and Google Maps, without the need to visit hospital websites or call.
In addition, inquiries that were previously scattered across WeChat, Line, Instagram, WhatsApp, and other platforms can now be centrally managed within Dr.palette, greatly reducing administrative workload for clinics. These updates not only improve efficiency but also enhance accessibility for international patients, reinforcing Dr.palette’s position as a leader in Korea’s evolving medical landscape.
Weavrcare’s Dr.palette Signs MOU for AI Skin Diagnosis Integration
This quarter, Weavrcare’s Dr.palette signed a memorandum of understanding (MOU) with Unien Korea to integrate EMR functionality with AI skin diagnostic devices, including Eve V and Eve M. By linking diagnostic results directly with patient records, this partnership enables clinics to provide more precise, efficient, and personalized care.
The collaboration also establishes a co-sales strategy, allowing both companies to jointly deliver comprehensive solutions tailored to medical institutions. Through this integration, dermatology and aesthetic clinics gain a competitive edge by leveraging AI-driven insights seamlessly within their existing EMR workflows.
Weavrcare Presents Stablecoin Innovation at the Digital Asset Committee Seminar
In September, Weavrcare, a key partner of MediBloc, participated in a seminar hosted by Korean National Assembly Member Byungdeok Min and the Digital Asset Committee, delivering a presentation titled “KRW Stablecoin as a Catalyst for K-Medical Innovation in Payments, Authentication, and Data.”
Leveraging the Panacea blockchain and the MED token developed by MediBloc, Weavrcare introduced a KRW stablecoin payment system designed to resolve long-standing issues in medical tourism, including complex foreign exchange processes and high transaction fees. Alongside this, a decentralized identity (DID) solution was proposed to simplify patient verification while maintaining security and reliability.
This presentation demonstrated how MediBloc’s Panacea ecosystem can expand beyond development into real-world applications, while Weavrcare, as a close collaborator, is actively building practical use cases on top of this foundation. By presenting these solutions directly to lawmakers and policymakers, Weavrcare reinforced its role as a valuable partner in applying MediBloc’s technology to the healthcare industry, creating momentum for regulatory frameworks that will enhance both MED token utility and the global competitiveness of K-Medical.
—
Q3 underscored MediBloc’s commitment to advancing the Panacea ecosystem on multiple fronts: enhancing Dr.palette to meet the needs of Korea’s foreign patient market, collaborating with partners such as Weavrcare to expand real-world applications with AI-driven solutions, and presenting blockchain-based innovations like stablecoin and DID to national policymakers.
As we enter the final quarter of 2025, MediBloc will continue to strengthen the technical maturity and reliability of Panacea while deepening partnerships that translate this technology into meaningful value for healthcare providers and patients. With the trust of our community and the dedication of our collaborators, we remain committed to building a secure, sustainable, and patient-centered healthcare ecosystem that elevates the global competitiveness of K-Medical.